Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $199,509.28 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 11,152 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, March 27th. The shares were sold at an average price of $17.89, for a total value of $199,509.28. Following the sale, the president now directly owns 2,362,899 shares in the company, valued at approximately $42,272,263.11. This trade represents a 0.47 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, March 19th, Dawn Christine Maroney sold 16,535 shares of Alignment Healthcare stock. The shares were sold at an average price of $16.40, for a total value of $271,174.00.
• On Monday, March 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.99, for a total value of $479,700.00.
• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.43, for a total value of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total transaction of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.72, for a total transaction of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.61, for a total transaction of $408,300.00.

Alignment Healthcare Stock Up 0.9 %

Shares of NASDAQ ALHC traded up $0.17 during mid-day trading on Friday, reaching $18.30. The company had a trading volume of 1,599,660 shares, compared to its average volume of 1,491,362. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. Alignment Healthcare, Inc. has a twelve month low of $4.46 and a twelve month high of $18.60. The stock’s 50 day moving average is $15.28 and its 200-day moving average is $12.97. The stock has a market capitalization of $3.51 billion, a PE ratio of -23.77 and a beta of 1.49.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Wellington Management Group LLP raised its stake in shares of Alignment Healthcare by 77.9% during the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company’s stock worth $83,683,000 after purchasing an additional 3,257,630 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its position in Alignment Healthcare by 54.7% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company’s stock valued at $97,302,000 after acquiring an additional 3,059,596 shares in the last quarter. Millennium Management LLC raised its position in Alignment Healthcare by 588.3% during the fourth quarter. Millennium Management LLC now owns 3,388,602 shares of the company’s stock valued at $38,122,000 after acquiring an additional 2,896,311 shares in the last quarter. Point72 Asset Management L.P. acquired a new stake in Alignment Healthcare in the fourth quarter valued at approximately $20,087,000. Finally, Broad Bay Capital Management LP bought a new stake in Alignment Healthcare in the fourth quarter worth approximately $18,804,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the company. William Blair reaffirmed an “outperform” rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Piper Sandler boosted their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the company an “overweight” rating in a report on Tuesday, March 4th. Bank of America raised their price objective on shares of Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a research note on Tuesday, March 4th. Stephens reissued an “overweight” rating and set a $17.00 target price on shares of Alignment Healthcare in a research note on Monday, February 24th. Finally, Stifel Nicolaus raised their target price on Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $14.83.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.